6minutes 
 News

Moderna advances two vax candidates against Omicron variants

The company is one of a number of vaccine makers developing new shots to tackle BA.4 and BA.5
Reuters Health
0
13 July 2022
Save
Please login to bookmark Close

Moderna is moving ahead with two Omicron vaccine candidates for the third quarter of the year.

One is designed against the BA.1 variant and another against BA.4 and BA.5.

Vaccine makers including Moderna and rival Pfizer are developing updated vaccines to target the fast-spreading Omicron subvariants BA.4 and BA.5, which have gained a foothold in countries across the world in recent weeks.

Moderna said its decision to develop the bivalent vaccines was based on different market preferences for shots against the subvariants.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .